Latest News

The latest and greatest from Flomics

Everything you wanted to know about cell-free RNA but were afraid to ask.

At Flomics, our research focuses on cfRNA and its potential as a powerful biomarker for early
disease detection. In this document, we address the most frequently asked questions about cfRNA, highlighting its
transformative impact on diagnostics and research. Most researchers and medical professionals are familiar with RNA, from messenger RNA (mRNA) which is crucial for protein synthesis to RNA vaccines that have combated COVID-19…

read more
Flomics crowdfunding campaign with Capital Cell

Flomics crowdfunding campaign with Capital Cell

Flomics just launched a crowdfunding campaign with Capital Cell, to support its validation studies on the early detection of different types of cancer, become a Flomics shareholder and Join us in the fight against cancer.
Flomics groundbreaking technology…

read more
€1.1 million funding round.

€1.1 million funding round.

€1.1 million funding round to drive our innovative blood analysis for the early detection of five types of cancer (colorectal, lung, breast, prostate, and pancreatic).
This funding round was led by a prominent US Family Office and supported by key investors such…

read more
Flomics press release – PCPP 2022

Flomics press release – PCPP 2022

Flomics Biotech, en colaboración con el Biobanco del Sistema Sanitario Público de Andalucía y Leitat Technological Center, consigue una ayuda de 449.695€ en el plan de proyectos de colaboración público-privada 2021 otorgada por la Agencia Estatal…

read more

Press

Flomics Newsletter

Stay up to date with Flomics news, get access to articles related to our services and don’t miss out on the most recent Biotech news and events.
Subscribe below:

Flomics
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.